Cosse Jean-Philippe, Sermeus Audrey, Vannuvel Kayleen, Ninane Noelle, Raes Martine, Michiels Carine
Laboratory of Biochemistry and Cellular Biology (URBC), FUNDP-University of Namur, 61 rue de Bruxelles, 5000 Namur, Belgium.
Mol Cancer. 2007 Sep 26;6:61. doi: 10.1186/1476-4598-6-61.
It is more and more recognized that hypoxia plays a role in the resistance of cancer cells to chemotherapy. However, the mechanisms underlying this resistance still need deeper understanding. The aim of this study was to investigate the effect of hypoxia on this process since hypoxia is one of the hallmarks of tumor environment.
The effect of hypoxia on the apoptosis induced by etoposide, one drug commonly used in chemotherapy, was investigated using three different cancer cell lines. Gene expression changes were also studied in order to delineate the mechanisms responsible for the hypoxia-induced chemoresistance. We observed that hypoxia differentially influenced etoposide-induced cell death according to the cancer cell type. While hypoxia inhibited apoptosis in hepatoma HepG2 cells, it had no influence in lung carcinoma A549 cells and further enhanced it in breast cancer MCF-7 cells. Etoposide increased p53 activity in all cell lines while hypoxia alone decreased it only in HepG2 cells. Hypoxia had no influence on the etoposide-induced p53 activity in A549, increased p53 abundance in MCF-7 cells but markedly decreased p53 activity in HepG2 cells. Using low density DNA arrays to detect the expression of genes involved in the regulation of apoptosis, etoposide and hypoxia were shown to each influence the expression of numerous genes, many of the ones influenced by etoposide being p53 target genes. Again, the influence of hypoxia on the etoposide-induced changes was different according to the cell type.
These results evidenced that there was a striking parallelism between the effect of hypoxia on the etoposide-induced p53 stabilization as well as p53 target gene expression and its effect on the etoposide-induced apoptosis according to the cell type. They are very interesting not only because they provide one possible mechanism for the induction of chemoresistance under hypoxic conditions in cells like HepG2 but also because they indicate that not all cell types respond the same way. This knowledge is of importance in designing adequate treatment according to the type of tumors.
越来越多的人认识到缺氧在癌细胞对化疗的耐药性中起作用。然而,这种耐药性的潜在机制仍需要更深入的了解。由于缺氧是肿瘤环境的特征之一,本研究的目的是探讨缺氧对这一过程的影响。
使用三种不同的癌细胞系研究了缺氧对化疗常用药物依托泊苷诱导的细胞凋亡的影响。还研究了基因表达变化,以阐明缺氧诱导化疗耐药的机制。我们观察到,缺氧根据癌细胞类型对依托泊苷诱导的细胞死亡有不同影响。虽然缺氧抑制肝癌HepG2细胞的凋亡,但对肺癌A549细胞没有影响,在乳腺癌MCF-7细胞中反而增强了凋亡。依托泊苷在所有细胞系中均增加p53活性,而单独缺氧仅在HepG2细胞中降低p53活性。缺氧对A549细胞中依托泊苷诱导的p53活性没有影响,在MCF-7细胞中增加了p53丰度,但在HepG2细胞中显著降低了p53活性。使用低密度DNA阵列检测参与凋亡调控的基因表达,结果显示依托泊苷和缺氧各自影响众多基因的表达,许多受依托泊苷影响的基因是p53靶基因。同样,缺氧对依托泊苷诱导变化的影响因细胞类型而异。
这些结果表明,缺氧对依托泊苷诱导的p53稳定以及p53靶基因表达的影响与它根据细胞类型对依托泊苷诱导凋亡的影响之间存在显著的平行关系。它们非常有趣,不仅因为它们为HepG2等细胞在缺氧条件下诱导化疗耐药提供了一种可能的机制,还因为它们表明并非所有细胞类型的反应方式都相同。这一知识对于根据肿瘤类型设计适当的治疗方法具有重要意义。